18928 Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 

Thomas Potterfield 

Mr. Potterfield, 31, holds an 

operator’s license from South Carolina. 

Thomas Prickett 

Mr. Prickett, 45, holds an operator’s 

license from Minnesota. 

Fernando Ramirez-Savon 

Mr. Ramirez-Savon, 45, holds a class 

A commercial driver’s license from New 

Mexico. 

Ralph Reno 

Mr. Reno, 43, holds an operator’s 

license from Pennsylvania. 

Ronald Rutter 

Mr. Rutter, 50, holds an operator’s 

license from Arizona. 

Russell Smith 

Mr. Smith, 44, holds an operator’s 

license from Ohio. 

James Weir 

Mr. Weir, 41, holds an operator’s 

license from Washington. 

Billy White 

Mr. White, 42, holds an operator’s 

license from Texas. 

E. Basis For Exemption 

Under 49 U.S.C. 31136(e) and 31315, 

FMCSA may grant an exemption from 

the hearing standard in 49 CFR 

391.41(b)(11) if the exemption is likely 

to achieve an equivalent or greater level 

of safety than would be achieved 

without the exemption. With the 

exemption, applicants can drive in 

interstate commerce. Thus, the Agency’s 

analysis focuses on whether an equal or 

greater level of safety is likely to be 

achieved by permitting each of these 

drivers to drive in interstate commerce 

as opposed to restricting him or her to 

driving in intrastate commerce. The 

driver must comply with the terms and 

conditions of the exemption. This 

includes reporting any crashes or 

accidents as defined in 49 CFR 390.5 

and reporting all citations and 

convictions for disqualifying offenses 

under 49 CFR part 383 and 49 CFR 391. 

Conclusion 

The Agency is granting exemptions 

from the hearing standard, 49 CFR 

391.41(b)(11), to 39 individuals based 

on an evaluation of each driver’s safety 

experience. Safety analysis of 

information relating to these 39 

applicants meets the burden of showing 

that granting the exemptions would 

achieve a level of safety that is 

equivalent to or greater than the level 

that would be achieved without the 

exemption. By granting the exemptions, 

the CMV industry will gain 39 

additional CMV drivers. In accordance 

with 49 U.S.C. 31315, each exemption 

will be valid for 2 years from the 

effective date with annual recertification 

required unless revoked earlier by 

FMCSA. The exemption will be revoked 

if the following occurs: (1) The person 

fails to comply with the terms and 

conditions of the exemption; (2) the 

exemption has resulted in a lower level 

of safety than was maintained prior to 

being granted; or (3) continuation of the 

exemption would not be consistent with 

the goals and objectives of 49 U.S.C. 

31136 and 31315. 

FMCSA exempts the following 39 

drivers for a period of 2 years from the 

physical qualification standard 

concerning hearing: Andrew Alcozer 

(IL); James Allen (VT); Michael Beebe 

(NJ); Shayne Bumbalough (WA); Barry 

Carpenter (SD); Gregorio Cerino-Perez 

(VA); Charles Cofield (MS); Chase Cook 

(VA); Barry Crisman (CA); Michael 

Desarmeaux (OH); Robert Douglas (CA); 

William Faulk (AL); Michael Fuller 

(NC); Daniel Grossinger (MD); Gregory 

Hill (MS); Kyle Hornung (WI); Ronald 

Jardine (NJ); Michael Jenkins (VA); 

Roman Landa (CA); Bryan Macfarlane 

(VT); Aminder Malhi (CA); Mark Martin 

(MI); Joshua Moothart (OR); Robert 

Munson (NJ); Jayson Lawson (AR); 

Albert Nicholson (NM); Darren 

Nordquist (WI); Edwin Oakes II (NY); 

Jeffrey Pagenkopf (MN); Jacob Paullin 

(WI); Ryan Pope (CA); Thomas 

Potterfield (SC); Thomas Prickett (MN); 

Fernando Ramirez-Savon (NM); Ralph 

Reno (PA); Ronald Rutter (AZ); Russell 

Smith (OH); James Weir (WA); and Billy 

White (TX). 

Dated: April 2, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–08062 Filed 4–7–15; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2015–0057] 

Qualification of Drivers; Exemption 

Applications; Diabetes Mellitus 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation. 

ACTION: Notice of applications for 

exemptions request for comments. 

SUMMARY: FMCSA announces receipt of 

applications from 49 individuals for 

exemption from the prohibition against 

persons with insulin-treated diabetes 

mellitus (ITDM) operating commercial 

motor vehicles (CMVs) in interstate 

commerce. If granted, the exemptions 

would enable these individuals with 

ITDM to operate CMVs in interstate 

commerce. 

DATES: Comments must be received on 

or before May 8, 2015. 

ADDRESSES: You may submit comments 

bearing the Federal Docket Management 

System (FDMS) Docket No. FMCSA– 

2015–0057 using any of the following 

methods: 

• Federal eRulemaking Portal: Go to 

http://www.regulations.gov. Follow the 

on-line instructions for submitting 

comments. 

• Mail: Docket Management Facility; 

U.S. Department of Transportation, 1200 

New Jersey Avenue SE., West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 

New Jersey Avenue SE., Washington, 

DC, between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal 

Holidays. 

• Fax: 1–202–493–2251. 

Instructions: Each submission must 

include the Agency name and the 

docket numbers for this notice. Note 

that all comments received will be 

posted without change to http://

www.regulations.gov, including any 

personal information provided. Please 

see the Privacy Act heading below for 

further information. 

Docket: For access to the docket to 

read background documents or 

comments, go to http://

www.regulations.gov at any time or 

Room W12–140 on the ground level of 

the West Building, 1200 New Jersey 

Avenue SE., Washington, DC, between 9 

a.m. and 5 p.m., Monday through 

Friday, except Federal holidays. The 

Federal Docket Management System 

(FDMS) is available 24 hours each day, 

365 days each year. If you want 

acknowledgment that we received your 

comments, please include a selfaddressed, stamped envelope or 

postcard or print the acknowledgement 

page that appears after submitting 

comments on-line. 

Privacy Act: In accordance with 5 

U.S.C. 553(c), DOT solicits comments 

from the public to better inform its 

rulemaking process. DOT posts these 

comments, without edit, including any 

personal information the commenter 

provides, to www.regulations.gov, as 

described in the system of records 

notice (DOT/ALL–14 FDMS), which can 

be reviewed at www.dot.gov/privacy. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 18929 

FOR FURTHER INFORMATION CONTACT: 

Charles A. Horan, III, Director, Carrier, 

Driver and Vehicle Safety Standards, 

(202) 366–4001, fmcsamedical@dot.gov, 

FMCSA, Department of Transportation, 

1200 New Jersey Avenue SE., Room 

W64–224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., Monday through Friday, except 

Federal holidays. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Under 49 U.S.C. 31136(e) and 31315, 

FMCSA may grant an exemption from 

the Federal Motor Carrier Safety 

Regulations for a 2-year period if it finds 

‘‘such exemption would likely achieve a 

level of safety that is equivalent to or 

greater than the level that would be 

achieved absent such exemption.’’ The 

statute also allows the Agency to renew 

exemptions at the end of the 2-year 

period. The 49 individuals listed in this 

notice have recently requested such an 

exemption from the diabetes prohibition 

in 49 CFR 391.41(b)(3), which applies to 

drivers of CMVs in interstate commerce. 

Accordingly, the Agency will evaluate 

the qualifications of each applicant to 

determine whether granting the 

exemption will achieve the required 

level of safety mandated by statute. 

II. Qualifications of Applicants 

Christopher R. Alba 

Mr. Alba, 35, has had ITDM since 

2014. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Alba understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Alba meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2015 and certified that he does 

not have diabetic retinopathy. He holds 

a Class B CDL from Colorado. 

Lloyd T. Beverly 

Mr. Beverly, 65, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Beverly understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Beverly meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Virginia. 

James R. Bledsoe 

Mr. Bledsoe, 65, has had ITDM since 

2001. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Bledsoe understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Bledsoe meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Florida. 

Sammy W. Bowlin 

Mr. Bowlin, 58, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Bowlin understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Bowlin meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Kansas. 

Durwin A. Brannon 

Mr. Brannon, 59, has had ITDM since 

2009. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Brannon understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Brannon meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from North Carolina. 

Larry J. Carril 

Mr. Carril, 64, has had ITDM since 

2014. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Carril understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Carril meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Illinois. 

Jimmy E. Cole 

Mr. Cole, 66, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Cole understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Cole meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2015 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from Tennessee. 

Richard S. Collins 

Mr. Collins, 45, has had ITDM since 

2013. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
18930 Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Collins understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Collins meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Iowa. 

Robert S. Colosimo 

Mr. Colosimo, 64, has had ITDM since 

2011. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Colosimo understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Colosimo meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from North 

Dakota. 

Joel F. Cook 

Mr. Cook, 40, has had ITDM since 

1990. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Cook understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Cook meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he has stable nonproliferative diabetic 

retinopathy. He holds a Class B CDL 

from New York. 

James N. Coombs 

Mr. Coombs, 52, has had ITDM since 

2015. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Coombs understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Coombs meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from New 

Jersey. 

David A. Daniels 

Mr. Daniels, 60, has had ITDM since 

2015. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Daniels understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Daniels meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Maine. 

Mark J. Dias 

Mr. Dias, 47, has had ITDM since 

2012. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Dias understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Dias meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2015 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from Massachusetts. 

William A. Emerick 

Mr. Emerick, 74, has had ITDM since 

2011. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Emerick understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Emerick meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Massachusetts. 

Brian A. Foss 

Mr. Foss, 38, has had ITDM since 

1982. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Foss understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Foss meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Wyoming. 

William A. H. Gardner 

Mr. Gardner, 44, has had ITDM since 

1981. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Gardner understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Gardner meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from California. 

Gary R. Gill 

Mr. Gill, 61, has had ITDM since 

2014. His endocrinologist examined him 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 18931 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Gill understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Gill meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from Pennsylvania. 

Steven M. Gilmour 

Mr. Gilmour, 55, has had ITDM since 

2014. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Gilmour understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Gilmour meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from 

Massachusetts. 

Ismael Gonzalez 

Mr. Gonzalez, 60, has had ITDM since 

2013. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Gonzalez understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Gonzalez meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds a Class A CDL from Indiana. 

Arnold P. Griffith, Jr. 

Mr. Griffith, 71, has had ITDM since 

2012. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Griffith understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Griffith meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Iowa. 

Charles A. Gudaitis 

Mr. Gudaitis, 50, has had ITDM since 

1994. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Gudaitis understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Gudaitis meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Pennsylvania. 

Scott D. Hanlon 

Mr. Hanlon, 58, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Hanlon understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Hanlon meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds a Class A CDL from New York. 

Cory A. Harker 

Mr. Harker, 24, has had ITDM since 

2000. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Harker understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Harker meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class C CDL from Florida. 

Stanley A. Head 

Mr. Head, 63, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Head understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Head meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from Georgia. 

David W. Henderson 

Mr. Henderson, 58, has had ITDM 

since 2012. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Henderson understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Henderson meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
18932 Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from North 

Carolina. 

Clark D. Holdeman 

Mr. Holdeman, 32, has had ITDM 

since 2007. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Holdeman understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Holdeman meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Texas. 

William E. Holt 

Mr. Holt, 58, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Holt understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Holt meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from Texas. 

David A. Holwegner 

Mr. Holwegner, 57, has had ITDM 

since 2014. His endocrinologist 

examined him in 2015 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Holwegner understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Holwegner meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Washington. 

Alan D. Jacobs 

Mr. Jacobs, 65, has had ITDM since 

2000. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Jacobs understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Jacobs meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from Oregon. 

Conrad J. Janik 

Mr. Janik, 61, has had ITDM since 

1973. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Janik understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Janik meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from New York. 

David F. Kenny 

Mr. Kenny, 52, has had ITDM since 

2014. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Kenny understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Kenny meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from New York. 

George W. Key, Jr. 

Mr. Key, 58, has had ITDM since 

2012. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Key understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Key meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2015 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from Alabama. 

Michael O. Lancial 

Mr. Lancial, 56, has had ITDM since 

2006. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Lancial understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Lancial meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds a chauffeur’s license from 

Michigan. 

Frank A. Mowers 

Mr. Mowers, 81, has had ITDM since 

2011. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 18933 

the last 5 years. His endocrinologist 

certifies that Mr. Mowers understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Mowers meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he does not have 

diabetic retinopathy. He holds a Class B 

CDL from Illinois. 

Charles H. Nichols 

Mr. Nichols, 51, has had ITDM since 

2008. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Nichols understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Nichols meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a 

chauffeur’s license from Michigan. 

Marvin R. Nunn 

Mr. Nunn, 57, has had ITDM since 

2010. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Nunn understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Nunn meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds an operator’s license from 

Oregon. 

Terry C. Rose 

Mr. Rose, 70, has had ITDM since 

2014. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Rose understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Rose meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

North Carolina. 

Robert L. Rush, Jr. 

Mr. Rush, 42, has had ITDM since 

2014. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Rush understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Rush meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2015 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from Pennsylvania. 

Derek J. Scougal 

Mr. Scougal, 35, has had ITDM since 

2009. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Scougal understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Scougal meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds a Class A CDL from Virginia. 

Roy Silva 

Mr. Silva, 59, has had ITDM since 

2000. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Silva understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Silva meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he has stable nonproliferative diabetic 

retinopathy. He holds a Class B CDL 

from Illinois. 

James L. Skinner 

Mr. Skinner, 46, has had ITDM since 

1975. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Skinner understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Skinner meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

proliferative diabetic retinopathy. He 

holds a Class A CDL from Iowa. 

Robert L. Terry 

Mr. Terry, 53, has had ITDM since 

2010. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Terry understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Terry meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from Tennessee. 

Rafael Torres, Jr. 

Mr. Torres, 54, has had ITDM since 

2014. His endocrinologist examined him 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
18934 Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 

1Section 4129(a) refers to the 2003 notice as a 

‘‘final rule.’’ However, the 2003 notice did not issue 

a ‘‘final rule’’ but did establish the procedures and 

standards for issuing exemptions for drivers with 

ITDM. 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Torres understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Torres meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Florida. 

Matthew C. Vaillancourt 

Mr. Vaillancourt, 27, has had ITDM 

since 2012. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Vaillancourt understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Vaillancourt meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Massachusetts. 

Joseph E. Weitzel 

Mr. Weitzel, 55, has had ITDM since 

2005. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Weitzel understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Weitzel meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2015 

and certified that he does not have 

diabetic retinopathy. He holds a Class B 

CDL from Pennsylvania. 

Ashley M. Winkels 

Ms. Winkels, 30, has had ITDM since 

2014. Her endocrinologist examined her 

in 2014 and certified that she has had 

no severe hypoglycemic reactions 

resulting in loss of consciousness, 

requiring the assistance of another 

person, or resulting in impaired 

cognitive function that occurred without 

warning in the past 12 months and no 

recurrent (2 or more) severe 

hypoglycemic episodes in the last 5 

years. Her endocrinologist certifies that 

Ms. Winkels understands diabetes 

management and monitoring, has stable 

control of her diabetes using insulin, 

and is able to drive a CMV safely. Ms. 

Winkels meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

Her optometrist examined her in 2015 

and certified that she does not have 

diabetic retinopathy. She holds an 

operator’s license from Minnesota. 

Steven L. Wolvers 

Mr. Wolvers, 56, has had ITDM since 

1995. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Wolvers understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Wolvers meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Iowa. 

David W. Wood 

Mr. Wood, 75, has had ITDM since 

2012. His endocrinologist examined him 

in 2015 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Wood understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Wood meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from Idaho. 

Donald E. Zimmerman 

Mr. Zimmerman, 70, has had ITDM 

since 2013. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Zimmerman understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Zimmerman meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2015 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from North 

Carolina. 

III. Request for Comments 

In accordance with 49 U.S.C. 31136(e) 

and 31315, FMCSA requests public 

comment from all interested persons on 

the exemption petitions described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

in the date section of the notice. 

FMCSA notes that section 4129 of the 

Safe, Accountable, Flexible and 

Efficient Transportation Equity Act: A 

Legacy for Users requires the Secretary 

to revise its diabetes exemption program 

established on September 3, 2003 (68 FR 

52441) 1. The revision must provide for 

individual assessment of drivers with 

diabetes mellitus, and be consistent 

with the criteria described in section 

4018 of the Transportation Equity Act 

for the 21st Century (49 U.S.C. 31305). 

Section 4129 requires: (1) Elimination 

of the requirement for 3 years of 

experience operating CMVs while being 

treated with insulin; and (2) 

establishment of a specified minimum 

period of insulin use to demonstrate 

stable control of diabetes before being 

allowed to operate a CMV. 

In response to section 4129, FMCSA 

made immediate revisions to the 

diabetes exemption program established 

by the September 3, 2003 notice. 

FMCSA discontinued use of the 3-year 

driving experience and fulfilled the 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 18935 

requirements of section 4129 while 

continuing to ensure that operation of 

CMVs by drivers with ITDM will 

achieve the requisite level of safety 

required of all exemptions granted 

under 49 U.S.C. 31136(e). 

Section 4129(d) also directed FMCSA 

to ensure that drivers of CMVs with 

ITDM are not held to a higher standard 

than other drivers, with the exception of 

limited operating, monitoring and 

medical requirements that are deemed 

medically necessary. 

The FMCSA concluded that all of the 

operating, monitoring and medical 

requirements set out in the September 3, 

2003 notice, except as modified, were in 

compliance with section 4129(d). 

Therefore, all of the requirements set 

out in the September 3, 2003 notice, 

except as modified by the notice in the 

Federal Register on November 8, 2005 

(70 FR 67777), remain in effect. 

IV. Submitting Comments 

You may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. 

To submit your comment online, go to 

http://www.regulations.gov and in the 

search box insert the docket number 

FMCSA–2015–0057 and click the search 

button. When the new screen appears, 

click on the blue ‘‘Comment Now!’’ 

button on the right hand side of the 

page. On the new page, enter 

information required including the 

specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. If you submit your 

comments by mail or hand delivery, 

submit them in an unbound format, no 

larger than 81⁄2 by 11 inches, suitable for 

copying and electronic filing. If you 

submit comments by mail and would 

like to know that they reached the 

facility, please enclose a stamped, selfaddressed postcard or envelope. 

We will consider all comments and 

material received during the comment 

period and may change this proposed 

rule based on your comments. FMCSA 

may issue a final rule at any time after 

the close of the comment period. 

V. Viewing Comments and Documents 

To view comments, as well as any 

documents mentioned in this preamble, 

To submit your comment online, go to 

http://www.regulations.gov and in the 

search box insert the docket number 

FMCSA–2015–0057 and click ‘‘Search.’’ 

Next, click ‘‘Open Docket Folder’’ and 

you will find all documents and 

comments related to the proposed 

rulemaking. 

Issued on: April 2, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–08053 Filed 4–7–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF TRANSPORTATION 

National Highway Traffic Safety 

Administration 

Denial of Motor Vehicle Defect Petition, 

DP14–002 

AGENCY: National Highway Traffic 

Safety Administration (NHTSA), 

Department of Transportation. 

ACTION: Denial of petition for a defect 

investigation. 

SUMMARY: This document denies a July 

7, 2014 petition from Mr. Brian Rosa of 

Union, NJ, requesting that the agency 

open an investigation into an alleged 

defect resulting in engine stall without 

warning after refueling in a model year 

(MY) 2007 Dodge Grand Caravan 

minivan. The petitioner’s vehicle is a 

Chrysler RS platform minivan. The RS 

platform includes MY 2003 through 

2007 Dodge Grand Caravan, Dodge 

Caravan, Chrysler Town and Country 

and Chrysler Voyager minivans. NHTSA 

evaluated the petition by analyzing 

consumer complaints submitted to the 

Agency, analyzing field data and 

reviewing technical information 

provided by Chrysler in response to an 

information request letter from the 

Agency, and testing an RS minivan that 

was the subject of a post-refuel engine 

stall complaint to NHTSA. After 

completing this evaluation, NHTSA has 

concluded that further investigation of 

the alleged defect in the subject vehicles 

is unlikely to result in a determination 

that a safety-related defect exists. The 

agency accordingly denies the petition. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Paul Simmons, Vehicle Control 

Division, Office of Defects Investigation, 

NHTSA, 1200 New Jersey Avenue SE., 

Washington, DC 20590. Telephone: 

(202) 366–2315. 

SUPPLEMENTARY INFORMATION: 

Alleged Defect 

The petitioner alleges that his MY 

2007 Dodge Grand Caravan vehicle 

experienced multiple incidents of 

engine stall without warning after 

refueling. The petitioner discovered that 

the defective part is a valve that is 

integral to the fuel tank, requiring tank 

replacement to repair the problem. The 

petitioner alleged that stalling without 

warning is an unreasonable risk to 

motor vehicle safety and requests the 

agency take action by opening a 

Preliminary Evaluation fully evaluate 

the defect. 

Engine Stall Defects 

The United States Code for Motor 

Vehicle Safety (Title 49, Chapter 301) 

defines motor vehicle safety as ‘‘the 

performance of a motor vehicle or motor 

vehicle equipment in a way that 

protects the public against unreasonable 

risk of accidents occurring because of 

the design, construction, or performance 

of a motor vehicle, and against 

unreasonable risk of death or injury in 

an accident, and includes 

nonoperational safety of a motor 

vehicle.’’ NHTSA considers several 

factors when assessing the safety risk 

posed by conditions that may result in 

engine stall while driving. These 

include the speeds at which stalling 

may occur, the ability of the driver to 

restart the vehicle, the warning available 

to the driver prior to stalling, the effects 

of engine stall on vehicle controllability, 

when and where the stalling will occur 

and the effects of the condition on other 

safety systems of the vehicle. In general, 

conditions that result in engine stall 

during low-speed operation at idle, such 

as when slowing to a stop, and which 

do not affect the operator’s ability to 

immediately restart the engine are 

considered the least hazardous types of 

stalling problems and, absent other 

safety factors, are not considered to be 

unreasonable risks to safety. 

Background (PE13–016) 

On February 10, 2014, ODI closed an 

investigation of an alleged defect in 

approximately 153,817 MY 2006 

Chrysler 300, Dodge Charger and Dodge 

Magnum vehicles (LX cars) that may 

result in engine stall shortly after 

refueling (PE13–016). In response to 

ODI’s information request for PE13–016, 

Chrysler identified a problem with the 

multifunction control valve (MFCV) fuel 

shutoff float integrated into 19-gallon 

fuel tanks in certain LX vehicles. 

According to Chrysler, the float may 

swell after exposure to fuels with high 

ethanol content, which may cause the 

valve to stick. A float valve that is stuck 

open during refueling, could result in 

fuel tank overfill and allow raw fuel to 

enter the purge line. This could result 

in problems with engine driveability 

(e.g., stumble or hesitation) or stall 

while driving in the brief period 

immediately after filling the fuel tank. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES